Literature DB >> 30739076

Multimodal MRI evaluation of parkinsonian limbic pathologies.

Ernest W Wang1, Guangwei Du1, Mechelle M Lewis2, Eun-Young Lee3, Sol De Jesus1, Sangam Kanekar4, Lan Kong5, Xuemei Huang6.   

Abstract

Previous multimodal magnetic resonance imaging (MRI) studies of parkinsonian syndromes have focused primarily on motor-related basal ganglia structures. The present study investigated MRI changes in nonmotor-related limbic structures in 35 Parkinson's disease, 16 multiple system atrophy parkinsonian subtype, 17 progressive supranuclear palsy, and 37 control subjects. Mean diffusivity (MD), fractional anisotropy, transverse relaxation rate (R2*), quantitative susceptibility mapping, and volume measurements were obtained from the amygdala, hippocampus, and nucleus accumbens (NAc) to examine differences between groups and to test for associations with clinical scores. Compared with controls, Parkinson's disease subjects had lower NAc volume; multiple system atrophy parkinsonian subtype subjects had higher NAc transverse relaxation rate; and progressive supranuclear palsy subjects had higher amygdala and hippocampus MD and lower hippocampus fractional anisotropy (p's ≤ 0.008). Among parkinsonian subjects, amygdala and hippocampus MD associated positively with Unified Parkinson's Disease Rating Scale nonmotor and activities of daily living scores (p's ≤ 0.005). Together, these findings support the inclusion of limbic structures in future MRI studies of parkinsonian syndromes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Limbic; Magnetic resonance imaging; Multiple system atrophy; Parkinson's disease; Progressive supranuclear palsy

Mesh:

Year:  2019        PMID: 30739076      PMCID: PMC6461740          DOI: 10.1016/j.neurobiolaging.2019.01.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  52 in total

1.  Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study.

Authors:  G A Carlesimo; F Piras; F Assogna; F E Pontieri; C Caltagirone; G Spalletta
Journal:  Neurology       Date:  2012-05-30       Impact factor: 9.910

2.  Age, Gender, Comorbidity, and the MDS-UPDRS: Results from a Population-Based Study.

Authors:  Mark R Keezer; Christina Wolfson; Ronald B Postuma
Journal:  Neuroepidemiology       Date:  2016-03-12       Impact factor: 3.282

Review 3.  Anxiety in Parkinson's disease: a critical review of experimental and clinical studies.

Authors:  Rui D S Prediger; Filipe C Matheus; Marcelo L Schwarzbold; Marcelo M S Lima; Maria A B F Vital
Journal:  Neuropharmacology       Date:  2011-08-31       Impact factor: 5.250

4.  Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for quantitative susceptibility mapping in MRI.

Authors:  Tian Liu; Weiyu Xu; Pascal Spincemaille; A Salman Avestimehr; Yi Wang
Journal:  IEEE Trans Med Imaging       Date:  2012-01-04       Impact factor: 10.048

5.  Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes.

Authors:  LingYu Zhang; Bei Cao; RuWei Ou; Qian-Qian Wei; Bi Zhao; Jing Yang; Ying Wu; HuiFang Shang
Journal:  Parkinsonism Relat Disord       Date:  2016-12-13       Impact factor: 4.891

6.  Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy.

Authors:  Maria Cristina Piattella; N Upadhyay; M Bologna; E Sbardella; F Tona; A Formica; N Petsas; A Berardelli; P Pantano
Journal:  J Neurol       Date:  2015-05-16       Impact factor: 4.849

Review 7.  Parkinson's disease and anxiety.

Authors:  K Walsh; G Bennett
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

8.  Memory impairment in patients with progressive supranuclear palsy.

Authors:  I Litvan; J Grafman; C Gomez; T N Chase
Journal:  Arch Neurol       Date:  1989-07

9.  Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.

Authors:  Gaetano Barbagallo; Maria Sierra-Peña; Federico Nemmi; Anne Pavy-Le Traon; Wassilios G Meissner; Olivier Rascol; Patrice Péran
Journal:  Mov Disord       Date:  2015-12-17       Impact factor: 10.338

10.  Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking.

Authors:  Garret D Stuber; Dennis R Sparta; Alice M Stamatakis; Wieke A van Leeuwen; Juanita E Hardjoprajitno; Saemi Cho; Kay M Tye; Kimberly A Kempadoo; Feng Zhang; Karl Deisseroth; Antonello Bonci
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

View more
  3 in total

Review 1.  Nucleus accumbens atrophy in Parkinson's disease (Mavridis' atrophy): 10 years later.

Authors:  Ioannis N Mavridis; Efstratios-Stylianos Pyrgelis
Journal:  Am J Neurodegener Dis       Date:  2022-06-20

2.  Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot Study.

Authors:  Gregory Brown; Guangwei Du; Elana Farace; Mechelle M Lewis; Paul J Eslinger; James McInerney; Lan Kong; Runze Li; Xuemei Huang; Sol De Jesus
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

3.  Prospective CERAD Neuropsychological Assessment in Patients With Multiple System Atrophy.

Authors:  Fabian Maass; Peter Hermann; Daniela Varges; Sabine Nuhn; Christoph van Riesen; Ala Jamous; Niels K Focke; Manuel Hewitt; Andreas Leha; Mathias Bähr; Inga Zerr
Journal:  Front Neurol       Date:  2022-07-19       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.